Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
- 1 April 2014
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 29 (4) , 261-275
Abstract
A number of biomarkers of inflammatory and metabolic pathways are individually related to higher risk of colorectal cancer (CRC); however, the association between biomarker patterns and CRC incidence has not been previously evaluated. Our study investigates the association of biomarker patterns with CRC in a prospective nested case–control study within the European Prospective Investigation into Cancer and Nutrition (EPIC). During median follow-up time of 7.0 (3.7–9.4) years, 1,260 incident CRC cases occurred and were matched to 1,260 controls using risk-set sampling. Pre-diagnostic measurements of C-peptide, glycated hemoglobin, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), C-reactive protein (CRP), reactive oxygen metabolites (ROM), insulin-like growth factor 1, adiponectin, leptin and soluble leptin receptor (sOB-R) were used to derive biomarker patterns from principal component analysis (PCA). The relation with CRC incidence was assessed using conditional logistic regression models. We identified four biomarker patterns ‘HDL-C/Adiponectin fractions’, ‘ROM/CRP’, ‘TG/C-peptide’ and ‘leptin/sOB-R’ to explain 60 % of the overall biomarker variance. In multivariable-adjusted logistic regression, the ‘HDL-C/Adiponectin fractions’, ‘ROM/CRP’ and ‘leptin/sOB-R’ patterns were associated with CRC risk [for the highest quartile vs the lowest, incidence rate ratio (IRR) = 0.69, 95 % CI 0.51–0.93, P-trend = 0.01; IRR = 1.70, 95 % CI 1.30–2.23, P-trend = 0.002; and IRR = 0.79, 95 % CI 0.58–1.07; P-trend = 0.05, respectively]. In contrast, the ‘TG/C-peptide’ pattern was not associated with CRC risk (IRR = 0.75, 95 % CI 0.56–1.00, P-trend = 0.24). After cases within the first 2 follow-up years were excluded, the ‘ROM/CRP’ pattern was no longer associated with CRC risk, suggesting potential influence of preclinical disease on these associations. By application of PCA, the study identified ‘HDL-C/Adiponectin fractions’, ‘ROM/CRP’ and ‘leptin/sOB-R’ as biomarker patterns representing potentially important pathways for CRC development.Keywords
This publication has 62 references indexed in Scilit:
- Plasma Adiponectin and Soluble Leptin Receptor and Risk of Colorectal Cancer: A Prospective StudyCancer Prevention Research, 2013
- Oxidative Stress in the Pathogenesis of Colorectal Cancer: Cause or Consequence?BioMed Research International, 2013
- Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer RiskCurrent Nutrition Reports, 2012
- Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition CohortCancer Research, 2012
- Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition StudyCarcinogenesis, 2012
- Biomarkers of Oxidative Stress and Risk of Developing Colorectal Cancer: A Cohort-nested Case-Control Study in the European Prospective Investigation Into Cancer and NutritionAmerican Journal of Epidemiology, 2012
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Serum levels of IGF‐I, IGFBP‐3 and colorectal cancer risk: results from the EPIC cohort, plus a meta‐analysis of prospective studiesInternational Journal of Cancer, 2010
- Diet and cancer — the European Prospective Investigation into Cancer and NutritionNature Reviews Cancer, 2004